General American Investors CO Inc Paratek Pharmaceuticals, Inc. Transaction History

General American Investors CO Inc

$1.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$1.52 - $2.8 $114,000 - $210,000	-75,000 Reduced 3.92%	1,839,424 $4.07 Million
Q1 2023 May 02, 2023	BUY	$1.37 - $2.54 $41,142 - $76,278	30,031 Added 1.59%	1,914,424 $4.86 Million
Q4 2022 Feb 10, 2023	SELL	$1.67 - $2.51 $52,949 - $79,582	-31,706 Reduced 1.65%	1,884,393 $3.52 Million
Q3 2022 Oct 31, 2022	BUY	$1.96 - $2.93 $320,712 - $479,432	163,629 Added 9.34%	1,916,099 $4.92 Million
Q2 2022 Aug 05, 2022	BUY	$1.73 - $3.09 $526,439 - $940,287	304,300 Added 21.01%	1,752,470 $3.38 Million
Q1 2022 May 02, 2022	BUY	$2.94 - $4.77 $415,277 - $673,767	141,251 Added 10.81%	1,448,170 $4.3 Million
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $790,642 - $1.03 Million	194,261 Added 17.46%	1,306,919 $5.87 Million
Q3 2021 Nov 01, 2021	BUY	$4.7 - $7.24 $335,866 - $517,377	71,461 Added 6.86%	1,112,658 $5.41 Million
Q2 2021 Aug 05, 2021	BUY	$6.81 - $10.93 $371,839 - $596,799	54,602 Added 5.53%	1,041,197 $7.1 Million
Q1 2021 May 03, 2021	SELL	$6.14 - $8.31 $86,917 - $117,636	-14,156 Reduced 1.41%	986,595 $6.97 Million
Q3 2020 Oct 30, 2020	BUY	$4.19 - $6.69 $607,709 - $970,304	145,038 Added 16.95%	1,000,751 $5.41 Million
Q2 2020 Aug 03, 2020	BUY	$2.97 - $5.22 $156,011 - $274,201	52,529 Added 6.54%	855,713 $4.47 Million
Q1 2020 May 01, 2020	BUY	$2.67 - $4.97 $424,158 - $789,539	158,861 Added 24.66%	803,184 $2.53 Million
Q4 2019 Feb 20, 2020	SELL	$2.93 - $4.5 $308,637 - $474,016	-105,337 Reduced 14.05%	644,323 $2.6 Million
Q3 2019 Oct 25, 2019	BUY	$3.08 - $5.76 $860,783 - $1.61 Million	279,475 Added 59.44%	749,660 $3.24 Million
Q2 2019 Aug 02, 2019	BUY	$3.47 - $6.32 $18,044 - $32,864	5,200 Added 1.12%	470,185 $1.88 Million
Q4 2018 Feb 15, 2019	BUY	$4.8 - $11.6 $137,380 - $332,003	28,621 Added 6.56%	464,985 $2.39 Million
Q3 2018 Oct 26, 2018	BUY	$9.05 - $10.95 $452,500 - $547,500	50,000 Added 12.94%	436,364 $4.23 Million
Q2 2018 Aug 03, 2018	BUY	$10.2 - $13.9 $790,500 - $1.08 Million	77,500 Added 25.09%	386,364 $3.94 Million
Q4 2017 Feb 13, 2018	SELL	$17.45 - $25.6 $669,190 - $981,734	-38,349 Reduced 11.04%	308,864 $5.53 Million
Q3 2017 Oct 27, 2017	BUY	$18.9 - $28.2 $6.56 Million - $9.79 Million	347,213	347,213 $8.72 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.

Account